title: Number needed to treat for pricing costly anticancer drugs: the example of regorafenib in metastatic colorectal cancer.
authors.affiliation: Department of Onco-Hematology, Azienda Ospedaliera 'Ospedali Riuniti Marche Nord', Pesaro frada@tin.it.
authors.forename: F
authors.initials: F
authors.lastname: Graziano
authors.affiliation: Clinical Research Laboratory, IRCCS Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Rulli
authors.affiliation: Clinical Research Laboratory, IRCCS Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Biagioli
authors.affiliation: Department of Onco-Hematology, Azienda Ospedaliera 'Ospedali Riuniti Marche Nord', Pesaro.
authors.forename: V
authors.initials: V
authors.lastname: Catalano
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D006801:Humans
chemical_list: D000970:Antineoplastic Agents